Dr. Weinsheimer’s research interests include human genetics studies of cerebrovascular malformations and neuropsychiatric disorders. Her group’s main focus is the identification of clinical genomics tools that can aid early detection, stratify patient subtypes and result in improved clinical management for individuals with brain vascular malformations including brain AVM, aneurysm, Cerebral Cavernous Malformation and Hereditary Hemorrhagic Telangiectasia. Current approaches include genome-wide association studies, screening for rare variants, investigation of somatic variation, and blood expression profiling to identify molecular markers of poor outcome.